BioSyent Inc. (TSXV:RX)
Canada
· Delayed Price · Currency is CAD 11.09
-0.01 (-0.09%)
Feb 21, 2025, 3:50 PM EST
BioSyent Revenue
BioSyent had revenue of 9.56M CAD in the quarter ending September 30, 2024, with 7.72% growth. This brings the company's revenue in the last twelve months to 34.51M, up 12.12% year-over-year. In the year 2023, BioSyent had annual revenue of 31.59M with 13.12% growth.
Revenue (ttm)
34.51M
Revenue Growth
+12.12%
P/S Ratio
3.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
125.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 31.59M | 3.67M | 13.12% |
| Dec 31, 2022 | 27.93M | -693.03K | -2.42% |
| Dec 31, 2021 | 28.62M | 6.29M | 28.15% |
| Dec 31, 2020 | 22.33M | 907.84K | 4.24% |
| Dec 31, 2019 | 21.42M | -102.70K | -0.48% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.51B |
| WELL Health Technologies | 957.69M |
| dentalcorp Holdings | 1.51B |
| Curaleaf Holdings | 1.83B |
| Sienna Senior Living | 893.16M |
| Trulieve Cannabis | 1.58B |
| Cronos Group | 150.26M |
| Extendicare | 1.42B |
BioSyent News
- 22 days ago - BioSyent declares CAD 0.05 dividend - Seeking Alpha
- 22 days ago - BioSyent Declares First Quarter 2025 Dividend - GlobeNewsWire
- 6 weeks ago - FAX Capital Files Early Warning Report Regarding Disposition of Common Shares of BioSyent Inc. - GlobeNewsWire
- 2 months ago - BioSyent Announces Renewal of Normal Course Issuer Bid - GlobeNewsWire
- 3 months ago - FAX Capital Files Early Warning Report Regarding Disposition of Common Shares of BioSyent Inc. - GlobeNewsWire
- 3 months ago - BioSyent reports GAAP EPS of C$0.20, revenue of C$9.56M - Seeking Alpha
- 3 months ago - BioSyent Releases Financial Results for Q3 and YTD 2024 - GlobeNewsWire
- 3 months ago - BioSyent Declares Fourth Quarter 2024 Dividend - GlobeNewsWire